Enhanced cancer detection through probe modification
US10292631B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2015 |
| Grant date | May 21, 2019 |
| Priority date | — |
| Expiry date | Nov 7, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H40/67
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Body-mountable devices are provided to detect the presence or status of a tumor in a body by detecting one or more properties of a probe located in subsurface vasculature of the body. A wearable body-mountable device can be worn for a protracted period of time to detect a probe in the vasculature at low concentrations and/or at low rates. A body-mountable device can detect properties of the probe that are indicative of whether the probe has interacted with a tumor of the body and determine the presence or status of a tumor in the body based on such detected properties. Additionally or alternatively, the probe could be introduced into the body as a probe aggregate and released from if the probe aggregate is absorbed by a tumor. The presence of released probes could be detected to determine a presence or status of a tumor in the body.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.